Article
Ex-vivo models of post-surgical residual disease in human glioblastoma
2024-11-04
Abstract excerpt
Background Glioblastoma is a highly infiltrative, currently incurable brain cancer. To date, translation of novel therapies for glioblastoma from the laboratory into clinical trials has relied heavily on in vitro cell culture and murine (subcutaneous and orthotopic) xenograft models using cells derived from the main bulk of patient tumours. However, it is the residual cells left-behind after surgery that are resp...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 719197ac-33d5-570e-97e1-3508936ad1a9
- DOI
- 10.12688/f1000research.157013.1
